China Genetic Testing Market By Type, Diseases, Technology, Services and Forecast By 2023

China Genetic Testing Market Report and Forecast Till 2023

Copyright © IMARC Service Pvt Ltd. All Rights Reserved

About IMARC Group

Report Description

IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

China Genetic Testing Market Report By Test Type (Prenatal Testing, Carrier Testing, New Born Testing, Predictive/Presymptomatic Testing and Diagnostic Testing), Disease (Cancer, Down Syndrome, Thalassemia and Others), Technology, Service, Testing Sample The China genetic testing market exhibited a positive growth over the recent years. The market growth is being led by factors including development of the domestic biotechnology sector and increasing investments from international players.

Market Overview: According to the latest report by IMARC Group, titled “China Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the China genetic testing market reached a value of US$ 1.43 Billion in 2017. Genetic tests identify the changes occurring in the genes, proteins or chromosomes of an individual. They help in determining the chances of a person passing on a genetic disorder to the next generation as well as their vulnerability to a suspected genetic disease.

The genetic testing market in China has witnessed rapid development since the establishment of the first genomics company in 1999. The demand for genetic testing services in the country is being driven by factors like aging population, expanding middle class and investments in the healthcare sector. The industry has also attracted international investors owing to rising demand for noninvasive prenatal testing and growing research in the fields of reproductive and oncology health.

Report Description and Highlights

Report Description Market Trends:

In an effort to expand its domestic biotechnology sector, the Chinese Government has taken steps in the favor of genetic science development. It identified genomics as a strategic field for the country’s social and economic development in its 14th Five-Year Plan. The Government also plans to document the genetic makeup of people from nine different minority groups, in an attempt to decode hereditary information within their genes. Apart from this, the market for direct-to-consumer DNA testing has also experienced massive growth driven by rising priority of personal health and wellness among consumers. This trend has further been supported by technological advancements which have reduced the cost of DNA sequencing services. However, there is a lack of specifically-designed educational programs for training medical genetic professionals in China.

Despite this hindrance, the China genetic testing market value is expected to reach US$ 4.33 Billion by 2023, at a projected CAGR of 18.9% during 2018-2023.

Request for a free sample report: https://www.imarcgroup.com/request?type=report&id=1111&flag=B

Market Forecast

Sample Figure: China: Genetic Testing Market Forecast: Value (in Million US$), 2018-2023

184.3

191.7

199.3

207.3

2018

2019

2020

2021

215.6

224.2

2022

2023

Market Segmentation

Report Description

China Genetic Testing Market Segmentation: Market Segmentation by Test Type o o o o o

Prenatal Testing, Carrier Testing, New Born Testing, Predictive/Presymptomatic Testing, Diagnostic Testing

On the basis of test type, the market is segmented into prenatal testing, newborn testing, diagnostic testing, carrier testing, predictive or presymptomatic testing and others. Amongst these, prenatal testing is the most popular segment.

For More information, Please Visit: http://bit.ly/2CADQPv

Market Segmentation

Report Description Market Segmentation by Disease • • • •

Cancer Down Syndrome Thalassemia Others

Based on diseases, the market has been segregated into cancer, Down syndrome, thalassemia and others. At present, cancer remains the leading cause of death in China owing to which genetic tests are gaining popularity as these tests help the doctors in identifying suitable medication for patients.

Market Segmentation by Technology • • •

Biochemical Molecular Cytogenetic

The market has been categorized on the basis of technologies into cytogenetic, biochemical and molecular. Amongst these, biochemical is the most common technology used for conducting genetic tests in China.

Market Segmentation

Report Description

Market Segmentation by Service Provider • • •

Hospital Based Laboratories Independent Laboratories Specialty Clinics

There are several service providers available in China for genetic testing such as hospital-based laboratories, independent laboratories and specialty clinics. Hospital-based laboratories exhibit a clear dominance in the market.

Market Segmentation by Testing Sample • • • •

Blood Saliva Hair Others

The report has analyzed the China genetic testing market according to different testing samples which include blood, saliva, hair and others. Amongst these, blood samples hold the majority of the market share.

Market Segmentation

Report Description Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players.

• • • • • • •

BGI, Shenzhen Huada Gene Technology Co Ltd., Berry Genomics Co. ltd., Daan Gene Co. Ltd, WuXi NextCODE, Annoroad Gene Technology Co. Ltd WuXi PharmaTech

In case you have a very specific customized or specific niche needs, we can work around the scope of work and assist you with the tailor made solution. The topics covered could be technology, markets, competition, pricing trends, P&L analysis, cost analysis, price bench marking or it could also be supplementing you with the weekly or fortnight reports.

Team Profile

Team Profile Our Team Comes From Some of the Top Universities Globally.

60% Engineering and Science

5% Others

35% Business Studies

Over 2000 Independent Consultants from different sectors.

Average Experience of 7+ Years

We are the trusted business partners to the

Partial List of Clients world's leading corporates, governments, and A partial List of our Clients institutions

We are the trusted business partners to the

Partial Listworld's of Clients leading corporates, governments, and

A partial List of our Clients

institutions

Report Description and Highlights

Report Description

© 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com